Home
Who, What & Why?
OA Now back issues
Open Access news
Open Access links
Bethesda principles
Advocacy/posters
Open Access forum
Contact us
 Search OA Now
Archive
1 December 2003 PDF (370 kB) 
Editorial
The need for a universal Open Access label. 'Open Access' is now being used to describe an increasingly diverse amount of website content.
[more][previous editorials]
Feature
More sophisticated strategies are needed for searching, accessing, and processing information within the scientific literature. Open Access Now talked to Les Grivell, Director of E-BioSci, which is an ambitious European initiative to create a powerful electronic information platform for the life sciences.
[more][previous features]
Research news from BioMed Central journals
Research published in Arthritis Research & Therapy details the uncovering of an enzyme which performs a pivotal role in the onset of arthritis.
[more][previous research]

Research published in BMC Developmental Biology suggests that C. elegans embryos require fatty-acid pathways to set up their anterior-posterior axes.
[more][previous research]

Tell a friend or colleague about BioMed Central before 14 December and you could win US$400 in Amazon gift certificates. Visit the BioMed Central site to enter our free prize draw.

News
The Australian government provides support for Open Access projects.
[more]
An Open Access editor speaks...
Raul Altman
Buenos Aires Thrombosis Center
Professor Raul Altman shares his thoughts on Open Access publishing.
[more][previous authors/editors]
Who, What & Why?
A regular short guide to the players, stakeholders and technical terms relevant to Open Access publishing. 'Who, What & Why?' helps readers to become informed about the world of Open Access.

This issue we feature the Berlin Declaration.
[more][previous WWW]
Open Access Journals
Use them, read them, cite them, and... submit to them.
To submit a manuscript or for more information, visit: www.biomedcentral.com/manuscript


 

 
 

Open Access Now is published by BioMed Central.
Editor: Jonathan B Weitzman.